Strides Pharma

{
  "main_header": {
    "sid": 688428,
    "name": "Strides Pharma",
    "stock_name": "Strides Pharma",
    "full_name": "Strides Pharma Science Ltd",
    "name_url": "stocks-analysis/strides-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "929.20",
    "chg": 18.4,
    "chgp": "2.02%",
    "dir": 1,
    "prev_price": "910.80",
    "mcapval": "8,420.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532531,
    "symbol": "STAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE939A01011",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "3.39 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Strides Pharma Science Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3902383",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_mojoScore_3902383.png",
        "date": "2026-03-20 08:05:54",
        "description": "Strides Pharma Science Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 March 2026. This change is primarily driven by a deterioration in technical indicators, despite the company’s robust recent financial performance and attractive valuation metrics. The downgrade reflects a nuanced assessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals."
      },
      {
        "title": "Strides Pharma Science Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-faces-mildly-bearish-technical-shift-amid-mixed-momentum-signals-3902267",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_technicaldot_3902267.png",
        "date": "2026-03-20 08:02:18",
        "description": "Strides Pharma Science Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a complex interplay of market forces impacting the small-cap pharmaceutical player."
      },
      {
        "title": "Strides Pharma Science Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-forms-death-cross-signalling-potential-bearish-trend-3901381",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_dealthcross_3901381.png",
        "date": "2026-03-19 18:00:15",
        "description": "Strides Pharma Science Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness ahead."
      },
      {
        "title": "Strides Pharma Science Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-is-rated-hold-by-marketsmojo-3896319",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_mojoScore_3896319.png",
        "date": "2026-03-17 10:10:17",
        "description": "Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 05 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 17 March 2026, providing investors with the latest insights into the company's performance and outlook."
      },
      {
        "title": "Strides Pharma Gains 1.65%: Technical Shift and Valuation Drive Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-gains-165-technical-shift-and-valuation-drive-weekly-momentum-3891708",
        "imagepath": "",
        "date": "2026-03-14 17:09:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> Stock opens at Rs.842.65, down 0.99% amid broad market weakness</p>\n                    <p><strong>4 Mar:</strong> Mildly bearish momentum confirmed as stock dips to Rs.831.80 (-1.29%)</p>\n                    <p><strong>5 Mar:</strong> MarketsMOJO upgrades rating to Hold; stock rallies 2.27% to Rs.850.65</p>\n                    <p><strong>6 Mar:</strong> Technical momentum shifts to mildly bullish; stock closes at Rs.865.05 (+1.69%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.842.65</div></div>\n                    <div class=\"stat-ite..."
      },
      {
        "title": "Strides Pharma Science Ltd Valuation Improves Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-valuation-improves-amid-strong-market-performance-3887999",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_valuationdot_3887999.png",
        "date": "2026-03-13 08:00:38",
        "description": "Strides Pharma Science Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating. This change reflects a recalibration of price-to-earnings and price-to-book value ratios, positioning the stock as a compelling option within the Pharmaceuticals & Biotechnology sector amid evolving market dynamics."
      },
      {
        "title": "Strides Pharma Science Ltd Upgraded to Hold on Improved Technicals and Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-upgraded-to-hold-on-improved-technicals-and-valuation-3875276",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_mojoScore_3875276.png",
        "date": "2026-03-06 08:04:13",
        "description": "Strides Pharma Science Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators alongside robust quarterly financial results. The upgrade, effective from 5 March 2026, is underpinned by enhanced technical trends, attractive valuation metrics, and a strong financial performance in Q3 FY25-26, despite some lingering concerns over long-term fundamentals and promoter share pledging."
      },
      {
        "title": "Strides Pharma Science Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-shows-technical-momentum-shift-amid-mixed-indicator-signals-3875186",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_technicaldot_3875186.png",
        "date": "2026-03-06 08:01:40",
        "description": "Strides Pharma Science Ltd has exhibited a notable shift in technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by improvements in daily moving averages and a recent upgrade in its Mojo Grade from Sell to Hold, signalling cautious optimism among investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Strides Pharma Science Ltd Faces Mildly Bearish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-faces-mildly-bearish-momentum-amid-mixed-technical-signals-3868211",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/StridesPharmaSc_technicaldot_3868211.png",
        "date": "2026-03-04 08:04:05",
        "description": "Strides Pharma Science Ltd has experienced a subtle shift in price momentum, with technical indicators signalling a transition from sideways movement to a mildly bearish trend. Despite some bullish cues on shorter-term moving averages, the broader weekly and monthly charts suggest caution for investors as the stock navigates a complex technical landscape."
      }
    ],
    "total": 663,
    "sid": "688428",
    "stock_news_url": "https://www.marketsmojo.com/news/strides-pharma-science-688428"
  },
  "announcements": [
    {
      "details": "Strides Pharma Science Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Strides Pharma Science Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.",
      "source": "NSE",
      "caption": "Strides Pharma Science Limited - Shareholders meeting",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Strides Pharma Science Limited has informed the Exchange regarding a press release dated November 08, 2019, titled \"Strides announces relaunch of Ranitidine tablets (Rx) for the US Market\".",
      "source": "NSE",
      "caption": "Strides Pharma Science Limited - Press Release",
      "datetime": "08-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Strides Pharma Science Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Jul 25",
          "dt": "2025-07-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Strides Pharma Science Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-03-20 08:05:54

Strides Pharma Science Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 March 2026. This change is primarily driven by a deterioration in technical indicators, despite the company’s robust recent financial performance and attractive valuation metrics. The downgrade reflects a nuanced assessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

Strides Pharma Science Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals

2026-03-20 08:02:18

Strides Pharma Science Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a complex interplay of market forces impacting the small-cap pharmaceutical player.

Read full news article

Strides Pharma Science Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-03-19 18:00:15

Strides Pharma Science Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness ahead.

Read full news article

Strides Pharma Science Ltd is Rated Hold by MarketsMOJO

2026-03-17 10:10:17

Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 05 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 17 March 2026, providing investors with the latest insights into the company's performance and outlook.

Read full news article

Strides Pharma Gains 1.65%: Technical Shift and Valuation Drive Weekly Momentum

2026-03-14 17:09:25

Key Events This Week

2 Mar: Stock opens at Rs.842.65, down 0.99% amid broad market weakness

4 Mar: Mildly bearish momentum confirmed as stock dips to Rs.831.80 (-1.29%)

5 Mar: MarketsMOJO upgrades rating to Hold; stock rallies 2.27% to Rs.850.65

6 Mar: Technical momentum shifts to mildly bullish; stock closes at Rs.865.05 (+1.69%)

Week Open

Rs.842.65

Read full news article

Strides Pharma Science Ltd Valuation Improves Amid Strong Market Performance

2026-03-13 08:00:38

Strides Pharma Science Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating. This change reflects a recalibration of price-to-earnings and price-to-book value ratios, positioning the stock as a compelling option within the Pharmaceuticals & Biotechnology sector amid evolving market dynamics.

Read full news article

Strides Pharma Science Ltd Upgraded to Hold on Improved Technicals and Valuation

2026-03-06 08:04:13

Strides Pharma Science Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators alongside robust quarterly financial results. The upgrade, effective from 5 March 2026, is underpinned by enhanced technical trends, attractive valuation metrics, and a strong financial performance in Q3 FY25-26, despite some lingering concerns over long-term fundamentals and promoter share pledging.

Read full news article

Strides Pharma Science Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals

2026-03-06 08:01:40

Strides Pharma Science Ltd has exhibited a notable shift in technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by improvements in daily moving averages and a recent upgrade in its Mojo Grade from Sell to Hold, signalling cautious optimism among investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Strides Pharma Science Ltd Faces Mildly Bearish Momentum Amid Mixed Technical Signals

2026-03-04 08:04:05

Strides Pharma Science Ltd has experienced a subtle shift in price momentum, with technical indicators signalling a transition from sideways movement to a mildly bearish trend. Despite some bullish cues on shorter-term moving averages, the broader weekly and monthly charts suggest caution for investors as the stock navigates a complex technical landscape.

Read full news article

View All News